These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8339545)

  • 1. Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta.
    Cetta G; Rossi A; Tenni R; Valli M; Forlino A; Zanaboni G; Dyne K; Burgio GR
    Connect Tissue Res; 1993; 29(1):41-9. PubMed ID: 8339545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta.
    Valli M; Rossi A; Forlino A; Tenni R; Cetta G
    Matrix; 1993 Jul; 13(4):275-80. PubMed ID: 8412984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deposition and selective degradation of structurally-abnormal type I collagen in a collagen matrix produced by osteogenesis imperfecta fibroblasts in vitro.
    Bateman JF; Golub SB
    Matrix Biol; 1994 Apr; 14(3):251-62. PubMed ID: 7921542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB. Molecules containing the shortened alpha2(I) chains show differential incorporation into the bone and skin extracellular matrix.
    Mundlos S; Chan D; Weng YM; Sillence DO; Cole WG; Bateman JF
    J Biol Chem; 1996 Aug; 271(35):21068-74. PubMed ID: 8702873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen defects in lethal perinatal osteogenesis imperfecta.
    Bateman JF; Chan D; Mascara T; Rogers JG; Cole WG
    Biochem J; 1986 Dec; 240(3):699-708. PubMed ID: 3827862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic comparison of an osteogenesis imperfecta type IV proband with a de novo alpha2(I) Gly922 --> Ser substitution in type I collagen and an unrelated patient with an identical mutation.
    Forlino A; D'amato E; Valli M; Camera G; Hopkins E; Marini JC; Cetta G; Coviello DA
    Biochem Mol Med; 1997 Oct; 62(1):26-35. PubMed ID: 9367795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Nicholas Andry Award-1996. The molecular pathology of osteogenesis imperfecta.
    Cole WG
    Clin Orthop Relat Res; 1997 Oct; (343):235-48. PubMed ID: 9345229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies of osteoblast and fibroblast type I collagen in a patient with osteogenesis imperfecta type IV.
    Galicka A; Wolczynski S; Gindzienski A
    J Pathol; 2002 Feb; 196(2):235-7. PubMed ID: 11793376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of an aspartic acid for glycine 700 in the alpha 2(I) chain of type I collagen in a recurrent lethal type II osteogenesis imperfecta dramatically affects the mineralization of bone.
    Cohen-Solal L; Zylberberg L; Sangalli A; Gomez Lira M; Mottes M
    J Biol Chem; 1994 May; 269(20):14751-8. PubMed ID: 8182080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.
    Bateman JF; Mascara T; Chan D; Cole WG
    Biochem J; 1984 Jan; 217(1):103-15. PubMed ID: 6421277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morphofunctional aspects of genetic analysis of osteogenesis imperfecta in cultured skin fibroblasts].
    Meerson EM; Barer FS; Berezhnyĭ AP; Prokhorova EV; Maliavko TP; Chernysheva EV; Neustroeva EP
    Biull Eksp Biol Med; 1992 Jul; 114(7):86-8. PubMed ID: 1421323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteogenesis imperfecta type IV: evidence of abnormal triple helical structure of type I collagen.
    Wenstrup RJ; Hunter AG; Byers PH
    Hum Genet; 1986 Sep; 74(1):47-53. PubMed ID: 3759085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta.
    Tenni R; Biglino P; Dyne K; Rossi A; Filocamo M; Pendola F; Brunelli P; Buttitta P; Borrone C; Cetta G
    J Inherit Metab Dis; 1991; 14(2):189-201. PubMed ID: 1886404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients.
    Mörike M; Brenner RE; Bushart GB; Teller WM; Vetter U
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):73-7. PubMed ID: 1520286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical signs and diagnosis of osteogenesis imperfecta in three dogs.
    Campbell BG; Wootton JA; Krook L; DeMarco J; Minor RR
    J Am Vet Med Assoc; 1997 Jul; 211(2):183-7. PubMed ID: 9227748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on type I collagen in skin fibroblasts cultured from twins with lethal osteogenesis imperfecta.
    Galicka A; Wołczyński S; Gindzieński A
    Acta Biochim Pol; 2003; 50(2):481-8. PubMed ID: 12833172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of mutant alpha (I)-procollagen in osteoblast and fibroblast cultures from a proband with osteogenesis imperfecta type IV.
    Chipman SD; Shapiro JR; McKinstry MB; Stover ML; Branson P; Rowe DW
    J Bone Miner Res; 1992 Jul; 7(7):793-805. PubMed ID: 1642148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure, stability and interactions of type I collagen with GLY349-CYS substitution in alpha 1(I) chain in a murine Osteogenesis Imperfecta model.
    Kuznetsova NV; Forlino A; Cabral WA; Marini JC; Leikin S
    Matrix Biol; 2004 May; 23(2):101-12. PubMed ID: 15246109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gly511 to Ser substitution in the COL1A1 gene in osteogenesis imperfecta type III patient with increased turnover of collagen.
    Galicka A; Wołczyński S; Gindzieński A; Surazyński A; Pałka J
    Mol Cell Biochem; 2003 Jun; 248(1-2):49-56. PubMed ID: 12870654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix.
    Valli M; Barnes AM; Gallanti A; Cabral WA; Viglio S; Weis MA; Makareeva E; Eyre D; Leikin S; Antoniazzi F; Marini JC; Mottes M
    Clin Genet; 2012 Nov; 82(5):453-9. PubMed ID: 21955071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.